APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Rehabilitation Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Rehabilitation Software Market Outlook and Growth Opportunities 2026

22 January 2026196 pages

Choose your research edition.

Industry ResearchAI Rehabilitation Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Rehabilitation Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal AI Rehabilitation Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Rehabilitation Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Rehabilitation Software Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI Rehabilitation Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Rehabilitation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Rehabilitation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Rehabilitation Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Rehabilitation Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Rehabilitation Software market include Abto Software, AlterG, Cardiolyse, Cerner, Commure, DocHQ, Exer AI, Limbic and MOVEnHeal, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Rehabilitation Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Rehabilitation Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Rehabilitation Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Rehabilitation Software market.

AI Rehabilitation Software Segment by Company

Abto Software

AlterG

Cardiolyse

Cerner

Commure

DocHQ

Exer AI

Limbic

MOVEnHeal

Raintree EMR

Sword

Wizecare

Wysa

AI Rehabilitation Software Segment by Type

Based on Machine Vision

Based on Wearable Sensors

Based on VR/AR/MR Devices

Based on Robots/Smart Hardware

AI Rehabilitation Software Segment by Application

Neurological Rehabilitation

Musculoskeletal Rehabilitation

Cardiopulmonary Rehabilitation

Geriatric and Chronic Disease Rehabilitation

Pediatric Rehabilitation

AI Rehabilitation Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Rehabilitation Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Rehabilitation Software key companies, revenue, market share, and recent developments.

3. To split the AI Rehabilitation Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Rehabilitation Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Rehabilitation Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Rehabilitation Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Rehabilitation Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Rehabilitation Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Rehabilitation Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Rehabilitation Software industry.

Chapter 3: Detailed analysis of AI Rehabilitation Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Rehabilitation Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Rehabilitation Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Rehabilitation Software Industry Trends Table 2. AI Rehabilitation Software Industry Drivers Table 3. AI Rehabilitation Software Industry Opportunities and Challenges Table 4. AI Rehabilitation Software Industry Restraints Table 5. Global AI Rehabilitation Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Rehabilitation Software Revenue Share by Company (2021-2026) Table 7. Global AI Rehabilitation Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Rehabilitation Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Rehabilitation Software Company, Product Type & Application Table 10. Global AI Rehabilitation Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Rehabilitation Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Based on Machine Vision Table 15. Significant Companies of Based on Wearable Sensors Table 16. Significant Companies of Based on VR/AR/MR Devices Table 17. Significant Companies of Based on Robots/Smart Hardware Table 18. Global AI Rehabilitation Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global AI Rehabilitation Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global AI Rehabilitation Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global AI Rehabilitation Software Sales Value Share by Type (2021-2026) Table 22. Global AI Rehabilitation Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Neurological Rehabilitation Table 24. Significant Companies of Musculoskeletal Rehabilitation Table 25. Significant Companies of Cardiopulmonary Rehabilitation Table 26. Significant Companies of Geriatric and Chronic Disease Rehabilitation Table 27. Significant Companies of Pediatric Rehabilitation Table 28. Global AI Rehabilitation Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global AI Rehabilitation Software Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global AI Rehabilitation Software Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global AI Rehabilitation Software Sales Value Share by Application (2021-2026) Table 32. Global AI Rehabilitation Software Sales Value Share by Application (2027-2032) Table 33. Global AI Rehabilitation Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global AI Rehabilitation Software Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global AI Rehabilitation Software Sales Value Share by Region (2021-2026) Table 36. Global AI Rehabilitation Software Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global AI Rehabilitation Software Sales Value Share by Region (2027-2032) Table 38. Global AI Rehabilitation Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global AI Rehabilitation Software Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global AI Rehabilitation Software Sales Value Market Share by Country (2021-2026) Table 41. Global AI Rehabilitation Software Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global AI Rehabilitation Software Sales Value Market Share by Country (2027-2032) Table 43. Abto Software Company Information Table 44. Abto Software Business Overview Table 45. Abto Software AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Abto Software AI Rehabilitation Software Product Portfolio Table 47. Abto Software Recent Development Table 48. AlterG Company Information Table 49. AlterG Business Overview Table 50. AlterG AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. AlterG AI Rehabilitation Software Product Portfolio Table 52. AlterG Recent Development Table 53. Cardiolyse Company Information Table 54. Cardiolyse Business Overview Table 55. Cardiolyse AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Cardiolyse AI Rehabilitation Software Product Portfolio Table 57. Cardiolyse Recent Development Table 58. Cerner Company Information Table 59. Cerner Business Overview Table 60. Cerner AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Cerner AI Rehabilitation Software Product Portfolio Table 62. Cerner Recent Development Table 63. Commure Company Information Table 64. Commure Business Overview Table 65. Commure AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Commure AI Rehabilitation Software Product Portfolio Table 67. Commure Recent Development Table 68. DocHQ Company Information Table 69. DocHQ Business Overview Table 70. DocHQ AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. DocHQ AI Rehabilitation Software Product Portfolio Table 72. DocHQ Recent Development Table 73. Exer AI Company Information Table 74. Exer AI Business Overview Table 75. Exer AI AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Exer AI AI Rehabilitation Software Product Portfolio Table 77. Exer AI Recent Development Table 78. Limbic Company Information Table 79. Limbic Business Overview Table 80. Limbic AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Limbic AI Rehabilitation Software Product Portfolio Table 82. Limbic Recent Development Table 83. MOVEnHeal Company Information Table 84. MOVEnHeal Business Overview Table 85. MOVEnHeal AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. MOVEnHeal AI Rehabilitation Software Product Portfolio Table 87. MOVEnHeal Recent Development Table 88. Raintree EMR Company Information Table 89. Raintree EMR Business Overview Table 90. Raintree EMR AI Rehabilitation Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Raintree EMR AI Rehabilitation Software Product Portfolio Table 92. Raintree EMR Recent Development Table 93. Sword Company Information Table 94. Sword Business Overview Table 95. Sword AI Rehabilitation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Sword AI Rehabilitation Software Product Portfolio Table 97. Sword Recent Development Table 98. Wizecare Company Information Table 99. Wizecare Business Overview Table 100. Wizecare AI Rehabilitation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Wizecare AI Rehabilitation Software Product Portfolio Table 102. Wizecare Recent Development Table 103. Wysa Company Information Table 104. Wysa Business Overview Table 105. Wysa AI Rehabilitation Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Wysa AI Rehabilitation Software Product Portfolio Table 107. Wysa Recent Development Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. AI Rehabilitation Software Product Image Figure 2. Global AI Rehabilitation Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Rehabilitation Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Rehabilitation Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Based on Machine Vision Image Figure 8. Based on Wearable Sensors Image Figure 9. Based on VR/AR/MR Devices Image Figure 10. Based on Robots/Smart Hardware Image Figure 11. Global AI Rehabilitation Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global AI Rehabilitation Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global AI Rehabilitation Software Sales Value Share by Type (2021-2032) Figure 14. Neurological Rehabilitation Image Figure 15. Musculoskeletal Rehabilitation Image Figure 16. Cardiopulmonary Rehabilitation Image Figure 17. Geriatric and Chronic Disease Rehabilitation Image Figure 18. Pediatric Rehabilitation Image Figure 19. Global AI Rehabilitation Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Rehabilitation Software Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global AI Rehabilitation Software Sales Value Share by Application (2021-2032) Figure 22. Global AI Rehabilitation Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global AI Rehabilitation Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America AI Rehabilitation Software Sales Value (2021-2032) & (US$ Million) Figure 25. North America AI Rehabilitation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe AI Rehabilitation Software Sales Value (2021-2032) & (US$ Million) Figure 27. Europe AI Rehabilitation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific AI Rehabilitation Software Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific AI Rehabilitation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America AI Rehabilitation Software Sales Value (2021-2032) & (US$ Million) Figure 31. South America AI Rehabilitation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa AI Rehabilitation Software Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa AI Rehabilitation Software Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt AI Rehabilitation Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Based on Machine Vision
  • Based on Wearable Sensors
  • Based on VR/AR/MR Devices
  • Based on Robots/Smart Hardware
Applications
  • Neurological Rehabilitation
  • Musculoskeletal Rehabilitation
  • Cardiopulmonary Rehabilitation
  • Geriatric and Chronic Disease Rehabilitation
  • Pediatric Rehabilitation
Companies covered
  • Abto Software
  • AlterG
  • Cardiolyse
  • Cerner
  • Commure
  • DocHQ
  • Exer AI
  • Limbic
  • MOVEnHeal
  • Raintree EMR
  • Sword
  • Wizecare
  • Wysa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Rehabilitation Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Rehabilitation Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Rehabilitation Software Market Dynamics
  1. 2.1 AI Rehabilitation Software Industry Trends
  2. 2.2 AI Rehabilitation Software Industry Drivers
  3. 2.3 AI Rehabilitation Software Industry Opportunities and Challenges
  4. 2.4 AI Rehabilitation Software Industry Restraints
3 AI Rehabilitation Software Market by Company
  1. 3.1 Global AI Rehabilitation Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Rehabilitation Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Rehabilitation Software Company Ranking (2024-2026)
  4. 3.4 Global AI Rehabilitation Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Rehabilitation Software Company Product Type and Application
  6. 3.6 Global AI Rehabilitation Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Rehabilitation Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Rehabilitation Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Rehabilitation Software Market by Type
  1. 4.1 AI Rehabilitation Software Type Introduction
  2. 4.1.1 Based on Machine Vision
  3. 4.1.2 Based on Wearable Sensors
  4. 4.1.3 Based on VR/AR/MR Devices
  5. 4.1.4 Based on Robots/Smart Hardware
  6. 4.2 Global AI Rehabilitation Software Sales Value by Type
  7. 4.2.1 Global AI Rehabilitation Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global AI Rehabilitation Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global AI Rehabilitation Software Sales Value Share by Type (2021-2032)
5 AI Rehabilitation Software Market by Application
  1. 5.1 AI Rehabilitation Software Application Introduction
  2. 5.1.1 Neurological Rehabilitation
  3. 5.1.2 Musculoskeletal Rehabilitation
  4. 5.1.3 Cardiopulmonary Rehabilitation
  5. 5.1.4 Geriatric and Chronic Disease Rehabilitation
  6. 5.1.5 Pediatric Rehabilitation
  7. 5.2 Global AI Rehabilitation Software Sales Value by Application
  8. 5.2.1 Global AI Rehabilitation Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global AI Rehabilitation Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global AI Rehabilitation Software Sales Value Share by Application (2021-2032)
6 AI Rehabilitation Software Regional Value Analysis
  1. 6.1 Global AI Rehabilitation Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Rehabilitation Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Rehabilitation Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Rehabilitation Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Rehabilitation Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Rehabilitation Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Rehabilitation Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Rehabilitation Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Rehabilitation Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Rehabilitation Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Rehabilitation Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Rehabilitation Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Rehabilitation Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Rehabilitation Software Sales Value Share by Country, 2025 VS 2032
7 AI Rehabilitation Software Country-level Value Analysis
  1. 7.1 Global AI Rehabilitation Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Rehabilitation Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Rehabilitation Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Rehabilitation Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Rehabilitation Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Rehabilitation Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Rehabilitation Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abto Software
  2. 8.1.1 Abto Software Company Information
  3. 8.1.2 Abto Software Business Overview
  4. 8.1.3 Abto Software AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abto Software AI Rehabilitation Software Product Portfolio
  6. 8.1.5 Abto Software Recent Developments
  7. 8.2 AlterG
  8. 8.2.1 AlterG Company Information
  9. 8.2.2 AlterG Business Overview
  10. 8.2.3 AlterG AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AlterG AI Rehabilitation Software Product Portfolio
  12. 8.2.5 AlterG Recent Developments
  13. 8.3 Cardiolyse
  14. 8.3.1 Cardiolyse Company Information
  15. 8.3.2 Cardiolyse Business Overview
  16. 8.3.3 Cardiolyse AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cardiolyse AI Rehabilitation Software Product Portfolio
  18. 8.3.5 Cardiolyse Recent Developments
  19. 8.4 Cerner
  20. 8.4.1 Cerner Company Information
  21. 8.4.2 Cerner Business Overview
  22. 8.4.3 Cerner AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cerner AI Rehabilitation Software Product Portfolio
  24. 8.4.5 Cerner Recent Developments
  25. 8.5 Commure
  26. 8.5.1 Commure Company Information
  27. 8.5.2 Commure Business Overview
  28. 8.5.3 Commure AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Commure AI Rehabilitation Software Product Portfolio
  30. 8.5.5 Commure Recent Developments
  31. 8.6 DocHQ
  32. 8.6.1 DocHQ Company Information
  33. 8.6.2 DocHQ Business Overview
  34. 8.6.3 DocHQ AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DocHQ AI Rehabilitation Software Product Portfolio
  36. 8.6.5 DocHQ Recent Developments
  37. 8.7 Exer AI
  38. 8.7.1 Exer AI Company Information
  39. 8.7.2 Exer AI Business Overview
  40. 8.7.3 Exer AI AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Exer AI AI Rehabilitation Software Product Portfolio
  42. 8.7.5 Exer AI Recent Developments
  43. 8.8 Limbic
  44. 8.8.1 Limbic Company Information
  45. 8.8.2 Limbic Business Overview
  46. 8.8.3 Limbic AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Limbic AI Rehabilitation Software Product Portfolio
  48. 8.8.5 Limbic Recent Developments
  49. 8.9 MOVEnHeal
  50. 8.9.1 MOVEnHeal Company Information
  51. 8.9.2 MOVEnHeal Business Overview
  52. 8.9.3 MOVEnHeal AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MOVEnHeal AI Rehabilitation Software Product Portfolio
  54. 8.9.5 MOVEnHeal Recent Developments
  55. 8.10 Raintree EMR
  56. 8.10.1 Raintree EMR Company Information
  57. 8.10.2 Raintree EMR Business Overview
  58. 8.10.3 Raintree EMR AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Raintree EMR AI Rehabilitation Software Product Portfolio
  60. 8.10.5 Raintree EMR Recent Developments
  61. 8.11 Sword
  62. 8.11.1 Sword Company Information
  63. 8.11.2 Sword Business Overview
  64. 8.11.3 Sword AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sword AI Rehabilitation Software Product Portfolio
  66. 8.11.5 Sword Recent Developments
  67. 8.12 Wizecare
  68. 8.12.1 Wizecare Company Information
  69. 8.12.2 Wizecare Business Overview
  70. 8.12.3 Wizecare AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wizecare AI Rehabilitation Software Product Portfolio
  72. 8.12.5 Wizecare Recent Developments
  73. 8.13 Wysa
  74. 8.13.1 Wysa Company Information
  75. 8.13.2 Wysa Business Overview
  76. 8.13.3 Wysa AI Rehabilitation Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Wysa AI Rehabilitation Software Product Portfolio
  78. 8.13.5 Wysa Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst